Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2005 (Vol. 25, No. 5)

Molecular Toolbox

URL:www.mgb.pitt.edu/moleculartoolbox.htm
  • Very thorough, well organized
  • none
There are so many links-only sites out there that I try to discriminate when covering such sites here. Molecular Toolbox is one links-based site that easily passed the scrutiny. Put together by Sidney Morris at the University of Pittsburgh, Molecular Toolbox scores well in several areas. First, it is well-organized, with clearly defined categories and carefully chosen links under each heading. Second, the breadth of coverage, while not comprehensive, is extensive and, like Goldilocks’ favorite porridge, just right. Third, the site is reasonably up-to-date, with few broken links. Interesting topic areas of the site include transgenic and knockouts; vector databases, multilink databases; Web-based tools; and structure prediction and analysis. It takes a lot of time to assemble this massive collection of links, put them together, and keep it up to date. I applaud the effort.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »